Bone mineral density before and after OLT: Long-term follow-up and predictive factors

被引:129
作者
Guichelaar, Maureen M. J.
Kendall, Rebecca
Hay, J. Eileen
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Biostat, Rochester, MN 55905 USA
关键词
D O I
10.1002/lt.20874
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Fracturing after liver transplantation (OLT) occurs due to the combination of preexisting low bone mineral density (BMD) and early posttransplant bone loss, the risk factors for which are poorly defined. The prevalence and predictive factors for hepatic osteopenia and osteoporosis, posttransplant bone loss, and subsequent bone gain were studied by the long-term posttransplant follow-up of 360 consecutive adult patients with end-stage primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). Only 20% of patients with advanced PBC or PSC have normal bone mass. Risk factors for low spinal BMD are low body mass index, older age, postmenopausal status, muscle wasting, high alkaline phosphatase and low serum albumin. A high rate of spinal bone loss occurred in the first 4 posttransplant months (annual rate of 16%) especially in those with younger age, PSC, higher pretransplant bone density, no inflammatory bowel disease, shorter duration of liver disease, current smoking, and ongoing cholestasis at 4 months. Factors favoring spinal bone gain from 4 to 24 months after transplantation were lower baseline and/or 4-month bone density, premenopausal status, lower cumulative glucocorticoids, no ongoing cholestasis, and higher levels of vitamin D and parathyroid hormone. Bone mass therefore improves most in patients with lowest pretransplant BMD who undergo successful transplantation with normal hepatic function and improved gonadal and nutritional status. Patients transplanted most recently have improved bone mass before OLT, and although bone loss still occurs early after OLT, these patients also have a greater recovery in BMD over the years following OLT.
引用
收藏
页码:1390 / 1402
页数:13
相关论文
共 52 条
  • [21] Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease
    Guichelaar, MMJ
    Malinchoc, M
    Sibonga, JD
    Clarke, BL
    Hay, JE
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (12) : 2190 - 2199
  • [22] Bone metabolism in advanced cholestatic liver disease: Analysis by bone histomorphometry
    Guichelaar, MMJ
    Malinchoc, M
    Sibonga, J
    Clarke, BL
    Hay, JE
    [J]. HEPATOLOGY, 2002, 36 (04) : 895 - 903
  • [23] Bone mineral density in the long term after liver transplantation
    Hamburg, SM
    Piers, DA
    van den Berg, AP
    Slooff, MJH
    Haagsma, EB
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 (07) : 600 - 606
  • [24] A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis
    Hay, JE
    Malinchoc, M
    Dickson, ER
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 (02) : 292 - 298
  • [25] HAY JE, 1991, HEPATOLOGY, V14, P257, DOI 10.1016/0270-9139(91)91412-T
  • [26] RATES OF CANCELLOUS BONE REMODELING AND TURNOVER IN OSTEOPENIA ASSOCIATED WITH PRIMARY BILIARY-CIRRHOSIS
    HODGSON, SF
    DICKSON, ER
    EASTELL, R
    ERIKSEN, EF
    BRYANT, SC
    RIGGS, BL
    [J]. BONE, 1993, 14 (06) : 819 - 827
  • [27] ROLE OF HYPERBILIRUBINEMIA IN THE IMPAIRMENT OF OSTEOBLAST PROLIFERATION-ASSOCIATED WITH CHOLESTATIC JAUNDICE
    JANES, CH
    DICKSON, ER
    OKAZAKI, R
    BONDE, S
    MCDONAGH, AF
    RIGGS, BL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) : 2581 - 2586
  • [28] KAO PC, 1984, CLIN CHEM, V30, P56
  • [29] KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO
  • [30] 2-L